Purine nucleosides: Endogenous neuroprotectants in hypoxic brain

Journal of Neurochemistry

Volumn 121, Issue 3, 2012, Pages 329-342

  Thauerer, Bettina ^a   Zur Nedden, Stephanie ^a   Baier Bitterlich, Gabriele ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

adenosine; guanosine; hypoxia; inosine; neuron; purine nucleosides

Indexed keywords

ADENOSINE; ADENOSINE A1 RECEPTOR; ADENOSINE A2A RECEPTOR; ADENOSINE A2B RECEPTOR; ADENOSINE A3 RECEPTOR; ADENOSINE PHOSPHATE; ADENOSINE TRIPHOSPHATE; EQUILIBRATIVE NUCLEOSIDE TRANSPORTER; GUANOSINE; GUANOSINE PHOSPHATE; GUANOSINE TRIPHOSPHATE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; INOSINE; MITOGEN ACTIVATED PROTEIN KINASE; PURINE NUCLEOSIDE; PURINE NUCLEOTIDE;

ANTIINFLAMMATORY ACTIVITY; BRAIN BLOOD FLOW; BRAIN HYPOXIA; BRAIN INFARCTION; BRAIN ISCHEMIA; BRAIN PROTECTION; CALCIUM HOMEOSTASIS; CYTOKINE PRODUCTION; HUMAN; NERVE CELL PLASTICITY; NERVE DEGENERATION; NERVE FIBER GROWTH; NERVOUS SYSTEM DEVELOPMENT; NEUROMODULATION; NEUROPROTECTION; NEUROTRANSMISSION; NEUROTRANSMITTER RELEASE; NONHUMAN; PRIORITY JOURNAL; REPERFUSION INJURY; REVIEW;

ANIMALS; CARRIER PROTEINS; HUMANS; HYPOXIA, BRAIN; NERVE REGENERATION; NEUROPROTECTIVE AGENTS; PURINE NUCLEOSIDES; RECEPTORS, PURINERGIC; SIGNAL TRANSDUCTION;

EID: 84859564539     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2012.07692.x     Document Type: Review

References (185)

1. Abbracchio M.P., Brambilla R., Ceruti S., Kim H.O., von Lubitz D.K., Jacobson K.A., and, Cattabeni F., (1995) G protein-dependent activation of phospholipase C by adenosine A3 receptors in rat brain. Mol. Pharmacol. 48, 1038-45.
2. Abbracchio M.P., Burnstock G., Verkhratsky A., and, Zimmermann H., (2009) Purinergic signalling in the nervous system: an overview. Trends Neurosci. 32, 19-29.
3. Albers G.W., Goldstein L.B., Hess D.C., Wechsler L.R., Furie K.L., Gorelick P.B., Hurn P., Liebeskind D.S., Nogueira R.G., and, Saver J.L., (2011) Stroke Treatment Academic Industry Roundtable (STAIR) recommendations for maximizing the use of intravenous thrombolytics and expanding treatment options with intra-arterial and neuroprotective therapies. Stroke 42, 2645-50.
4. Alessandrini A., Namura S., Moskowitz M.A., and, Bonventre J.V., (1999) MEK1 protein kinase inhibition protects against damage resulting from focal cerebral ischemia. Proc. Natl Acad. Sci. USA 96, 12866-9.
5. Arslan G., and, Fredholm B.B., (2000) Stimulatory and inhibitory effects of adenosine A(2A) receptors on nerve growth factor-induced phosphorylation of extracellular regulated kinases 1/2 in PC12 cells. Neurosci. Lett. 292, 183-6.
6. Arslan G., Kull B., and, Fredholm B.B., (1999) Signaling via A2A adenosine receptor in four PC12 cell clones. Naunyn. Schmiedebergs. Arch. Pharmacol. 359, 28-32.
7. Ballerini P., Ciccarelli R., Di Iorio P., et al. (2006) Guanosine effect on cholesterol efflux and apolipoprotein E expression in astrocytes. Purinergic Signal. 2, 637-49.
8. Barone F.C., and, Feuerstein G.Z., (1999) Inflammatory mediators and stroke: new opportunities for novel therapeutics. J. Cereb. Blood Flow Metab. 19, 819-34.
9. Bau C., Middlemiss P.J., Hindley S., Jiang S., Ciccarelli R., Caciagli F., Diiorio P., Werstiuk E.S., and, Rathbone M.P., (2005) Guanosine stimulates neurite outgrowth in PC12 cells via activation of heme oxygenase and cyclic GMP. Purinergic Signal. 1, 161-72.
10. Benowitz L.I., and, Carmichael S.T., (2010) Promoting axonal rewiring to improve outcome after stroke. Neurobiol. Dis. 37, 259-66.
11. Benowitz L.I., Jing Y., Tabibiazar R., Jo S.A., Petrausch B., Stuermer C.A., Rosenberg P.A., and, Irwin N., (1998) Axon outgrowth is regulated by an intracellular purine-sensitive mechanism in retinal ganglion cells. J. Biol. Chem. 273, 29626-34.
12. Benowitz L.I., Goldberg D.E., Madsen J.R., Soni D., and, Irwin N., (1999) Inosine stimulates extensive axon collateral growth in the rat corticospinal tract after injury. Proc. Natl Acad. Sci. USA 96, 13486-90.
13. Benowitz L.I., Goldberg D.E., and, Irwin N., (2002) Inosine stimulates axon growth in vitro and in the adult CNS. Prog. Brain Res. 137, 389-99.
14. Berger R., and, Garnier Y., (1999) Pathophysiology of perinatal brain damage. Brain Res. Brain Res. Rev. 30, 107-34.
15. Bickler P.E., and, Donohoe P.H., (2002) Adaptive responses of vertebrate neurons to hypoxia. J. Exp. Biol. 205, 3579-86.
16. Bocklinger K., Tomaselli B., Heftberger V., Podhraski V., Bandtlow C., and, Baier-Bitterlich G., (2004) Purine nucleosides support the neurite outgrowth of primary rat cerebellar granule cells after hypoxia. Eur. J. Cell Biol. 83, 51-4.
17. Boulton T.G., Nye S.H., Robbins D.J., Ip N.Y., Radziejewska E., Morgenbesser S.D., DePinho R.A., Panayotatos N., Cobb M.H., and, Yancopoulos G.D., (1991) ERKs: a family of protein-serine/threonine kinases that are activated and tyrosine phosphorylated in response to insulin and NGF. Cell 65, 663-75.
18. Braun N., Zhu Y., Krieglstein J., Culmsee C., and, Zimmermann H., (1998) Upregulation of the enzyme chain hydrolyzing extracellular ATP after transient forebrain ischemia in the rat. J. Neurosci. 18, 4891-900.
19. Burnstock G., (2008) Purinergic signalling and disorders of the central nervous system. Nat. Rev. Drug Discov. 7, 575-90.
20. van Calker D., Muller M., and, Hamprecht B., (1979) Adenosine regulates via two different types of receptors, the accumulation of cyclic AMP in cultured brain cells. J. Neurochem. 33, 999-1005.
21. Cao Y.J., Shibata T., and, Rainov N.G., (2002) Liposome-mediated transfer of the bcl-2 gene results in neuroprotection after in vivo transient focal cerebral ischemia in an animal model. Gene Ther. 9, 415-9.
22. Chang R., Algird A., Bau C., Rathbone M.P., and, Jiang S., (2008) Neuroprotective effects of guanosine on stroke models in vitro and in vivo. Neurosci. Lett. 431, 101-5.
23. Charles M.P., Adamski D., Kholler B., Pelletier L., Berger F., and, Wion D., (2003) Induction of neurite outgrowth in PC12 cells by the bacterial nucleoside N6-methyldeoxyadenosine is mediated through adenosine A2a receptors and via cAMP and MAPK signaling pathways. Biochem. Biophys. Res. Commun. 304, 795-800.
24. Chen G.Y., and, Nunez G., (2010) Sterile inflammation: sensing and reacting to damage. Nat. Rev. Immunol. 10, 826-37.
25. Chen J.F., Huang Z., Ma J., Zhu J., Moratalla R., Standaert D., Moskowitz M.A., Fink J.S., and, Schwarzschild M.A., (1999) A(2A) adenosine receptor deficiency attenuates brain injury induced by transient focal ischemia in mice. J. Neurosci. 19, 9192-200.
26. Chen P., Goldberg D.E., Kolb B., Lanser M., and, Benowitz L.I., (2002) Inosine induces axonal rewiring and improves behavioral outcome after stroke. Proc. Natl Acad. Sci. USA 99, 9031-6.
27. Cheung E.C., and, Slack R.S., (2004) Emerging role for ERK as a key regulator of neuronal apoptosis. Sci. STKE 2004, PE45.
28. Ciccarelli R., Di Iorio P., Giuliani P., D'Alimonte I., Ballerini P., Caciagli F., and, Rathbone M.P., (1999) Rat cultured astrocytes release guanine-based purines in basal conditions and after hypoxia/hypoglycemia. Glia 25, 93-8.
29. Ciccarelli R., Di Iorio P., D'Alimonte I., Giuliani P., Florio T., Caciagli F., Middlemiss P.J., and, Rathbone M.P., (2000) Cultured astrocyte proliferation induced by extracellular guanosine involves endogenous adenosine and is raised by the co-presence of microglia. Glia 29, 202-11.
30. Colucci-D'Amato L., Perrone-Capano C., and, di Porzio U., (2003) Chronic activation of ERK and neurodegenerative diseases. BioEssays 25, 1085-95.
31. Conrad P.W., Conforti L., Kobayashi S., Beitner-Johnson D., Rust R.T., Yuan Y., Kim H.W., Kim R.H., Seta K., and, Millhorn D.E., (2001) The molecular basis of O2-sensing and hypoxia tolerance in pheochromocytoma cells. Comp. Biochem. Physiol. B Biochem. Mol. Biol. 128, 187-204.
32. Cunha R.A., (2005) Neuroprotection by adenosine in the brain: from A(1) receptor activation to A (2A) receptor blockade. Purinergic Signal. 1, 111-34.
33. Dai S.S., and, Zhou Y.G., (2011) Adenosine 2A receptor: a crucial neuromodulator with bidirectional effect in neuroinflammation and brain injury. Rev. Neurosci. 22, 231-9.
34. Dal-Cim T., Martins W.C., Santos A.R., and, Tasca C.I., (2011) Guanosine is neuroprotective against oxygen/glucose deprivation in hippocampal slices via large conductance Ca(2)+-activated K+ channels, phosphatidilinositol-3 kinase/protein kinase B pathway activation and glutamate uptake. Neuroscience 183, 212-20.
35. Dale N., Pearson T., and, Frenguelli B.G., (2000) Direct measurement of adenosine release during hypoxia in the CA1 region of the rat hippocampal slice. J. Physiol., 14, 3-55.
36. D'Alimonte I., Flati V., D'Auro M., et al. (2007) Guanosine inhibits CD40 receptor expression and function induced by cytokines and beta amyloid in mouse microglia cells. J. Immunol. 178, 720-31.
37. Deaglio S., Dwyer K.M., Gao W., et al. (2007) Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression. J. Exp. Med. 204, 1257-65.
38. Delaney S.M., Shepel P.N., and, Geiger J.D., (1998) Levels of endogenous adenosine in rat striatum I. Regulation by ionotropic glutamate receptors, nitric oxide and free radicals. J. Pharmacol. Exp. Ther. 285, 561-7.
39. Deussen A., Lloyd H.G., and, Schrader J., (1989) Contribution of S-adenosylhomocysteine to cardiac adenosine formation. J. Mol. Cell. Cardiol. 21, 773-82.
40. Dickenson J.M., Blank J.L., and, Hill S.J., (1998) Human adenosine A1 receptor and P2Y2-purinoceptor-mediated activation of the mitogen-activated protein kinase cascade in transfected CHO cells. Br. J. Pharmacol. 124, 1491-9.
41. Dunwiddie T.V., and, Masino S.A., (2001) The role and regulation of adenosine in the central nervous system. Annu. Rev. Neurosci. 24, 31-55.
42. El-Khodor B.F., and, Boksa P., (2000) Transient birth hypoxia increases behavioral responses to repeated stress in the adult rat. Behav. Brain Res. 107, 171-5.
43. Eltzschig H.K., (2009) Adenosine: an old drug newly discovered. Anesthesiology 111, 904-15.
44. Faure M., Voyno-Yasenetskaya T.A., and, Bourne H.R., (1994) cAMP and beta gamma subunits of heterotrimeric G proteins stimulate the mitogen-activated protein kinase pathway in COS-7 cells. J. Biol. Chem. 269, 7851-4.
45. Fields R.D., and, Burnstock G., (2006) Purinergic signalling in neuron-glia interactions. Nat. Rev. Neurosci. 7, 423-36.
46. Fredholm B.B., (2007) Adenosine, an endogenous distress signal, modulates tissue damage and repair. Cell Death Differ. 14, 1315-23.
47. Fredholm B.B., (2010) Adenosine receptors as drug targets. Exp. Cell Res. 316, 1284-8.
48. Fredholm B.B., Abbracchio M.P., Burnstock G., Daly J.W., Harden T.K., Jacobson K.A., Leff P., and, Williams M., (1994) Nomenclature and classification of purinoceptors. Pharmacol. Rev. 46, 143-56.
49. Fredholm B.B., AP I.J., Jacobson K.A., Klotz K.N., and, Linden J., (2001a) International Union of Pharmacology XXV. Nomenclature and classification of adenosine receptors. Pharmacol. Rev. 53, 527-52.
50. Fredholm B.B., Irenius E., Kull B., and, Schulte G., (2001b) Comparison of the potency of adenosine as an agonist at human adenosine receptors expressed in Chinese hamster ovary cells. Biochem. Pharmacol. 61, 443-8.
51. Fredholm B.B., Chen J.F., Cunha R.A., Svenningsson P., and, Vaugeois J.M., (2005a) Adenosine and brain function. Int. Rev. Neurobiol. 63, 191-270.
52. Fredholm B.B., Chen J.F., Masino S.A., and, Vaugeois J.M., (2005b) Actions of adenosine at its receptors in the CNS: insights from knockouts and drugs. Annu. Rev. Pharmacol. Toxicol. 45, 385-412.
53. Fredholm B.B., Chern Y., Franco R., and, Sitkovsky M., (2007) Aspects of the general biology of adenosine A2A signaling. Prog. Neurobiol. 83, 263-76.
54. Fredholm B.B., AP I.J., Jacobson K.A., Linden J., and, Muller C.E., (2011) International Union of Basic and Clinical Pharmacology LXXXI. Nomenclature and classification of adenosine receptors - an update. Pharmacol. Rev. 63, 1-34.
55. Frenguelli B.G., Llaudet E., and, Dale N., (2003) High-resolution real-time recording with microelectrode biosensors reveals novel aspects of adenosine release during hypoxia in rat hippocampal slices. J. Neurochem. 86, 1506-15.
56. Frizzo M.E., Lara D.R., Prokopiuk Ade S., Vargas C.R., Salbego C.G., Wajner M., and, Souza D.O., (2002) Guanosine enhances glutamate uptake in brain cortical slices at normal and excitotoxic conditions. Cell. Mol. Neurobiol. 22, 353-63.
57. Ginsberg M.D., (2009) Current status of neuroprotection for cerebral ischemia: synoptic overview. Stroke 40, S111-4.
58. Greene L.A., and, Tischler A.S., (1976) Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor. Proc. Natl Acad. Sci. USA 73, 2424-8.
59. Gysbers J.W., and, Rathbone M.P., (1996a) Neurite outgrowth in PC12 cells is enhanced by guanosine through both cAMP-dependent and -independent mechanisms. Neurosci. Lett. 220, 175-8.
60. Gysbers J.W., and, Rathbone M.P., (1996b) GTP and guanosine synergistically enhance NGF-induced neurite outgrowth from PC12 cells. Int. J. Dev. Neurosci. 14, 19-34.
61. Hasko G., Kuhel D.G., Nemeth Z.H., Mabley J.G., Stachlewitz R.F., Virag L., Lohinai Z., Southan G.J., Salzman A.L., and, Szabo C., (2000) Inosine inhibits inflammatory cytokine production by a posttranscriptional mechanism and protects against endotoxin-induced shock. J. Immunol. 164, 1013-9.
62. Hasko G., Sitkovsky M.V., and, Szabo C., (2004) Immunomodulatory and neuroprotective effects of inosine. Trends Pharmacol. Sci. 25, 152-7.
63. Hasko G., Pacher P., Vizi E.S., and, Illes P., (2005) Adenosine receptor signaling in the brain immune system. Trends Pharmacol. Sci. 26, 511-6.
64. Haun S.E., Segeleon J.E., Trapp V.L., Clotz M.A., and, Horrocks L.A., (1996) Inosine mediates the protective effect of adenosine in rat astrocyte cultures subjected to combined glucose-oxygen deprivation. J. Neurochem. 67, 2051-9.
65. Heftberger V., Tomaselli B., Podhraski V., and, Baier-Bitterlich G., (2005) Purine nucleoside mediated protection of primary cerebellar granule cells after hypoxic insult. In Focus on Neurochemistry Research, (Nova Science Publ.) IX, 229-47.
66. Henke R.M., Dastidar R.G., Shah A., Cadinu D., Yao X., Hooda J., and, Zhang L., (2011) Hypoxia elicits broad and systematic changes in protein subcellular localization. Am. J. Physiol. Cell Physiol. 301, C913-28.
67. Hertz L., (2008) Bioenergetics of cerebral ischemia: a cellular perspective. Neuropharmacology 55, 289-309.
68. Hetman M., and, Gozdz A., (2004) Role of extracellular signal regulated kinases 1 and 2 in neuronal survival. Eur. J. Biochem. 271, 2050-5.
69. Hide I., Padgett W.L., Jacobson K.A., and, Daly J.W., (1992) A2A adenosine receptors from rat striatum and rat pheochromocytoma PC12 cells: characterization with radioligand binding and by activation of adenylate cyclase. Mol. Pharmacol. 41, 352-9.
70. Honig L.S., and, Rosenberg R.N., (2000) Apoptosis and neurologic disease. Am. J. Med. 108, 317-30.
71. Impey S., Obrietan K., and, Storm D.R., (1999) Making new connections: role of ERK/MAP kinase signaling in neuronal plasticity. Neuron 23, 11-4.
72. Ipata P.L., Camici M., Micheli V., and, Tozz M.G., (2011) Metabolic network of nucleosides in the brain. Curr. Top. Med. Chem. 11, 909-22.
73. Irving E.A., and, Bamford M., (2002) Role of mitogen- and stress-activated kinases in ischemic injury. J. Cereb. Blood Flow Metab. 22, 631-47.
74. Irwin N., Li Y.M., O'Toole J.E., and, Benowitz L.I., (2006) Mst3b, a purine-sensitive Ste20-like protein kinase, regulates axon outgrowth. Proc. Natl Acad. Sci. USA 103, 18320-5.
75. Jiang S., Bendjelloul F., Ballerini P., D'Alimonte I., Nargi E., Jiang C., Huang X., and, Rathbone M.P., (2007) Guanosine reduces apoptosis and inflammation associated with restoration of function in rats with acute spinal cord injury. Purinergic Signal. 3, 411-21.
76. Jin X., Shepherd R.K., Duling B.R., and, Linden J., (1997) Inosine binds to A3 adenosine receptors and stimulates mast cell degranulation. J. Clin. Invest. 100, 2849-57.
77. Johansson B., Halldner L., Dunwiddie T.V., et al. (2001) Hyperalgesia, anxiety, and decreased hypoxic neuroprotection in mice lacking the adenosine A1 receptor. Proc. Natl Acad. Sci. USA 98, 9407-12.
78. Johnson G.L., and, Lapadat R., (2002) Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases. Science 298, 1911-2.
79. Jurkowitz M.S., Litsky M.L., Browning M.J., and, Hohl C.M., (1998) Adenosine, inosine, and guanosine protect glial cells during glucose deprivation and mitochondrial inhibition: correlation between protection and ATP preservation. J. Neurochem. 71, 535-48.
80. King A.E., Ackley M.A., Cass C.E., Young J.D., and, Baldwin S.A., (2006) Nucleoside transporters: from scavengers to novel therapeutic targets. Trends Pharmacol. Sci. 27, 416-25.
81. Kinouchi H., Imaizumi S., Yoshimoto T., and, Motomiya M., (1990) Phenytoin affects metabolism of free fatty acids and nucleotides in rat cerebral ischemia. Stroke 21, 1326-32.
82. Kitagawa H., Mori A., Shimada J., Mitsumoto Y., and, Kikuchi T., (2002) Intracerebral adenosine infusion improves neurological outcome after transient focal ischemia in rats. Neurol. Res. 24, 317-23.
83. Kobayashi S., and, Millhorn D.E., (1999) Stimulation of expression for the adenosine A2A receptor gene by hypoxia in PC12 cells A potential role in cell protection. J. Biol. Chem. 274, 20358-65.
84. Kobayashi S., Conforti L., Pun R.Y., and, Millhorn D.E., (1998) Adenosine modulates hypoxia-induced responses in rat PC12 cells via the A2A receptor. J. Physiol., 508 (Pt 1), 95-107.
85. Koeppen M., Eckle T., and, Eltzschig H.K., (2011) The hypoxia-inflammation link and potential drug targets. Curr. Opin. Anaesthesiol. 24, 363-9.
86. Kusano Y., Echeverry G., Miekisiak G., Kulik T.B., Aronhime S.N., Chen J.F., and, Winn H.R., (2010) Role of adenosine A2 receptors in regulation of cerebral blood flow during induced hypotension. J. Cereb. Blood Flow Metab. 30, 808-15.
87. Lai D.M., Tu Y.K., Liu I.M., and, Cheng J.T., (2005) Increase of adenosine A1 receptor gene expression in cerebral ischemia of Wistar rats. Neurosci. Lett. 387, 59-61.
88. Latini S., and, Pedata F., (2001) Adenosine in the central nervous system: release mechanisms and extracellular concentrations. J. Neurochem. 79, 463-84.
89. Laubach V.E., French B.A., and, Okusa M.D., (2011) Targeting of adenosine receptors in ischemia-reperfusion injury. Expert. Opin. Ther. Targets 15, 103-18.
90. Li Y., Oskouian R.J., Day Y.J., Rieger J.M., Liu L., Kern J.A., and, Linden J., (2006) Mouse spinal cord compression injury is reduced by either activation of the adenosine A2A receptor on bone marrow-derived cells or deletion of the A2A receptor on non-bone marrow-derived cells. Neuroscience 141, 2029-39.
91. Linden J., (1991) Structure and function of A1 adenosine receptors. Faseb J. 5, 2668-76.
92. Lipton P., (1999) Ischemic cell death in brain neurons. Physiol. Rev. 79, 1431-568.
93. Litsky M.L., Hohl C.M., Lucas J.H., and, Jurkowitz M.S., (1999) Inosine and guanosine preserve neuronal and glial cell viability in mouse spinal cord cultures during chemical hypoxia. Brain Res. 821, 426-32.
94. Lloyd H.G., Lindstrom K., and, Fredholm B.B., (1993) Intracellular formation and release of adenosine from rat hippocampal slices evoked by electrical stimulation or energy depletion. Neurochem. Int. 23, 173-85.
95. Lo E.H., (2008) A new penumbra: transitioning from injury into repair after stroke. Nat. Med. 14, 497-500.
96. Lopes L.V., Sebastiao A.M., and, Ribeiro J.A., (2011) Adenosine and related drugs in brain diseases: present and future in clinical trials. Curr. Top. Med. Chem. 11, 1087-101.
97. Lorber B., Howe M.L., Benowitz L.I., and, Irwin N., (2009) Mst3b, an Ste20-like kinase, regulates axon regeneration in mature CNS and PNS pathways. Nat. Neurosci. 12, 1407-14.
98. Lu Y., and, Settleman J., (1999) The Drosophila Pkn protein kinase is a Rho/Rac effector target required for dorsal closure during embryogenesis. Genes Dev. 13, 1168-80.
99. von Lubitz D.K., (1999) Adenosine and cerebral ischemia: therapeutic future or death of a brave concept? Eur. J. Pharmacol. 371, 85-102.
100. Macrez R., Ali C., Toutirais O., Le Mauff B., Defer G., Dirnagl U., and, Vivien D., (2011) Stroke and the immune system: from pathophysiology to new therapeutic strategies. Lancet Neurol. 10, 471-80.
101. Majmundar A.J., Wong W.J., and, Simon M.C., (2010) Hypoxia-inducible factors and the response to hypoxic stress. Mol. Cell 40, 294-309.
102. Meghji P., Tuttle J.B., and, Rubio R., (1989) Adenosine formation and release by embryonic chick neurons and glia in cell culture. J. Neurochem. 53, 1852-60.
103. Meller R., Minami M., Cameron J.A., Impey S., Chen D., Lan J.Q., Henshall D.C., and, Simon R.P., (2005) CREB-mediated Bcl-2 protein expression after ischemic preconditioning. J. Cereb. Blood Flow Metab. 25, 234-46.
104. Mellor H., and, Parker P.J., (1998) The extended protein kinase C superfamily. Biochem. J. 332 (Pt 2), 281-92.
105. Minet E., Arnould T., Michel G., Roland I., Mottet D., Raes M., Remacle J., and, Michiels C., (2000) ERK activation upon hypoxia: involvement in HIF-1 activation. FEBS Lett. 468, 53-8.
106. Ming G.L., and, Song H., (2011) Adult neurogenesis in the mammalian brain: significant answers and significant questions. Neuron 70, 687-702.
107. Modha R., Campbell L.J., Nietlispach D., Buhecha H.R., Owen D., and, Mott H.R., (2008) The Rac1 polybasic region is required for interaction with its effector PRK1. J. Biol. Chem. 283, 1492-500.
108. Moskowitz M.A., Lo E.H., and, Iadecola C., (2010) The science of stroke: mechanisms in search of treatments. Neuron 67, 181-98.
109. Mukai H., (2003) The structure and function of PKN, a protein kinase having a catalytic domain homologous to that of PKC. J. Biochem. (Tokyo) 133, 17-27.
110. Muller C.E., and, Jacobson K.A., (2011) Recent developments in adenosine receptor ligands and their potential as novel drugs. Biochim. Biophys. Acta 1808, 1290-308.
111. Nagasawa K., Kawasaki F., Tanaka A., Nagai K., and, Fujimoto S., (2007) Characterization of guanine and guanosine transport in primary cultured rat cortical astrocytes and neurons. Glia 55, 1397-404.
112. Neary J.T., (2005) Protein kinase signaling cascades in CNS trauma. IUBMB Life 57, 711-8.
113. Neary J.T., Rathbone M.P., Cattabeni F., Abbracchio M.P., and, Burnstock G., (1996) Trophic actions of extracellular nucleotides and nucleosides on glial and neuronal cells. Trends Neurosci. 19, 13-8.
114. zur Nedden S., Tomaselli B., and, Baier-Bitterlich G., (2008) HIF-1 alpha is an essential effector for purine nucleoside-mediated neuroprotection against hypoxia in PC12 cells and primary cerebellar granule neurons. J. Neurochem. 105, 1901-14.
115. Nicole O., Ali C., Docagne F., Plawinski L., MacKenzie E.T., Vivien D., and, Buisson A., (2001) Neuroprotection mediated by glial cell line-derived neurotrophic factor: involvement of a reduction of NMDA-induced calcium influx by the mitogen-activated protein kinase pathway. J. Neurosci. 21, 3024-33.
116. Northington F.J., Chavez-Valdez R., and, Martin L.J., (2011) Neuronal cell death in neonatal hypoxia-ischemia. Ann. Neurol. 69, 743-58.
117. Ohta A., and, Sitkovsky M., (2001) Role of G-protein-coupled adenosine receptors in downregulation of inflammation and protection from tissue damage. Nature 414, 916-20.
118. Oleskovicz S.P., Martins W.C., Leal R.B., and, Tasca C.I., (2008) Mechanism of guanosine-induced neuroprotection in rat hippocampal slices submitted to oxygen-glucose deprivation. Neurochem. Int. 52, 411-8.
119. Palmer T.M., and, Stiles G.L., (1995) Adenosine receptors. Neuropharmacology 34, 683-94.
120. Palmer T.M., and, Stiles G.L., (1997) Structure-function analysis of inhibitory adenosine receptor regulation. Neuropharmacology 36, 1141-7.
121. Parkinson F.E., and, Xiong W., (2004) Stimulus- and cell-type-specific release of purines in cultured rat forebrain astrocytes and neurons. J. Neurochem. 88, 1305-12.
122. Parkinson F.E., Zhang Y.W., Shepel P.N., Greenway S.C., Peeling J., and, Geiger J.D., (2000) Effects of nitrobenzylthioinosine on neuronal injury, adenosine levels, and adenosine receptor activity in rat forebrain ischemia. J. Neurochem. 75, 795-802.
123. Parkinson F.E., Xiong W., and, Zamzow C.R., (2005) Astrocytes and neurons: different roles in regulating adenosine levels. Neurol. Res. 27, 153-60.
124. Parkinson F.E., Damaraju V.L., Graham K., Yao S.Y., Baldwin S.A., Cass C.E., and, Young J.D., (2011) Molecular biology of nucleoside transporters and their distributions and functions in the brain. Curr. Top. Med. Chem. 11, 948-72.
125. Pastor-Anglada M., Casado F.J., Valdes R., Mata J., Garcia-Manteiga J., and, Molina M., (2001) Complex regulation of nucleoside transporter expression in epithelial and immune system cells. Mol. Membr. Biol. 18, 81-5.
126. Peterfreund R.A., MacCollin M., Gusella J., and, Fink J.S., (1996) Characterization and expression of the human A2a adenosine receptor gene. J. Neurochem. 66, 362-8.
127. Petrausch B., Tabibiazar R., Roser T., Jing Y., Goldman D., Stuermer C.A., Irwin N., and, Benowitz L.I., (2000) A purine-sensitive pathway regulates multiple genes involved in axon regeneration in goldfish retinal ganglion cells. J. Neurosci. 20, 8031-41.
128. Pignataro G., Simon R.P., and, Boison D., (2007) Transgenic overexpression of adenosine kinase aggravates cell death in ischemia. J. Cereb. Blood Flow Metab. 27, 1-5.
129. van der Ploeg I., Ahlberg S., Parkinson F.E., Olsson R.A., and, Fredholm B.B., (1996) Functional characterization of adenosine A2 receptors in Jurkat cells and PC12 cells using adenosine receptor agonists. Naunyn. Schmiedebergs. Arch. Pharmacol. 353, 250-60.
130. Podhraski V., Tomaselli B., and, Baier-Bitterlich G., (2005) Adenosine receptor expression in PC12-cells during normoxic and hypoxic conditions. J. Neurochem. Suppl. 2, 210-266.
131. Press C., and, Milbrandt J., (2009) The purine nucleosides adenosine and guanosine delay axonal degeneration in vitro. J. Neurochem. 109, 595-602.
132. Rathbone M.P., Middlemiss P., Andrew C., Caciagli F., Ciccarelli R., Di Iorio P., and, Huang R., (1998) The trophic effects of purines and purinergic signaling in pathologic reactions of astrocytes. Alzheimer Dis. Assoc. Disord. 12 (Suppl. 2), S36-45.
133. Rathbone M.P., Middlemiss P.J., Gysbers J.W., Andrew C., Herman M.A., Reed J.K., Ciccarelli R., Di Iorio P., and, Caciagli F., (1999) Trophic effects of purines in neurons and glial cells. Prog. Neurobiol. 59, 663-90.
134. Rathbone M., Pilutti L., Caciagli F., and, Jiang S., (2008) Neurotrophic effects of extracellular guanosine. Nucleosides Nucleotides Nucl. Acids 27, 666-72.
135. Rathbone M.P., Saleh T.M., Connell B.J., Chang R., Su C., Worley B., Kim M., and, Jiang S., (2011) Systemic administration of guanosine promotes functional and histological improvement following an ischemic stroke in rats. Brain Res. 1407, 79-89.
136. Rebola N., Pinheiro P.C., Oliveira C.R., Malva J.O., and, Cunha R.A., (2003) Subcellular localization of adenosine A(1) receptors in nerve terminals and synapses of the rat hippocampus. Brain Res. 987, 49-58.
137. Rudolphi K.A., Schubert P., Parkinson F.E., and, Fredholm B.B., (1992) Neuroprotective role of adenosine in cerebral ischaemia. Trends Pharmacol. Sci. 13, 439-45.
138. Schaller B., Graf R., and, Jacobs A.H., (2003) Ischaemic tolerance: a window to endogenous neuroprotection? Lancet 362, 1007-8.
139. Schmidt A.P., Lara D.R., and, Souza D.O., (2007) Proposal of a guanine-based purinergic system in the mammalian central nervous system. Pharmacol. Ther. 116, 401-16.
140. Schulte G., and, Fredholm B.B., (2003a) The G(s)-coupled adenosine A(2B) receptor recruits divergent pathways to regulate ERK1/2 and p38. Exp. Cell Res. 290, 168-76.
141. Schulte G., and, Fredholm B.B., (2003b) Signalling from adenosine receptors to mitogen-activated protein kinases. Cell. Signal. 15, 813-27.
142. Sciotti V.M., Roche F.M., Grabb M.C., and, Van Wylen D.G., (1992) Adenosine receptor blockade augments interstitial fluid levels of excitatory amino acids during cerebral ischemia. J. Cereb. Blood Flow Metab. 12, 646-55.
143. Sebastiao A.M., (2011) Neuronal ENT1 takes up synaptic adenosine even under hypoxia/ischemia. J. Neurochem. 118, 1-3.
144. Segal R.A., and, Greenberg M.E., (1996) Intracellular signaling pathways activated by neurotrophic factors. Annu. Rev. Neurosci. 19, 463-89.
145. Seidel M.G., Klinger M., Freissmuth M., and, Holler C., (1999) Activation of mitogen-activated protein kinase by the A(2A)-adenosine receptor via a rap1-dependent and via a p21(ras)-dependent pathway. J. Biol. Chem. 274, 25833-41.
146. Semenza G.L., (2000) HIF-1 and human disease: one highly involved factor. Genes Dev. 14, 1983-91.
147. Semenza G.L., (2007) Life with oxygen. Science 318, 62-4.
148. Semenza G.L., (2011) Hypoxia-inducible factor 1: regulator of mitochondrial metabolism and mediator of ischemic preconditioning. Biochim. Biophys. Acta 1813, 1263-8.
149. Seta K.A., and, Millhorn D.E., (2004) Functional genomics approach to hypoxia signaling. J. Appl. Physiol. 96, 765-73.
150. Seta K.A., Spicer Z., Yuan Y., Lu G., and, Millhorn D.E., (2002) Responding to hypoxia: lessons from a model cell line. Sci. STKE 2002, RE11.
151. Sexl V., Mancusi G., Holler C., Gloria-Maercker E., Schutz W., and, Freissmuth M., (1997) Stimulation of the mitogen-activated protein kinase via the A2A-adenosine receptor in primary human endothelial cells. J. Biol. Chem. 272, 5792-9.
152. Shen H., Chen G.J., Harvey B.K., Bickford P.C., and, Wang Y., (2005) Inosine reduces ischemic brain injury in rats. Stroke 36, 654-9.
153. Sitkovsky M.V., (2009) T regulatory cells: hypoxia-adenosinergic suppression and re-direction of the immune response. Trends Immunol. 30, 102-8.
154. Sitkovsky M., and, Lukashev D., (2005) Regulation of immune cells by local-tissue oxygen tension: HIF1 alpha and adenosine receptors. Nat. Rev. Immunol. 5, 712-21.
155. Sitkovsky M.V., Lukashev D., Apasov S., Kojima H., Koshiba M., Caldwell C., Ohta A., and, Thiel M., (2004) Physiological control of immune response and inflammatory tissue damage by hypoxia-inducible factors and adenosine A2A receptors. Annu. Rev. Immunol. 22, 657-82.
156. Soricelli A., Postiglione A., Cuocolo A., De Chiara S., Ruocco A., Brunetti A., Salvatore M., and, Ell P.J., (1995) Effect of adenosine on cerebral blood flow as evaluated by single-photon emission computed tomography in normal subjects and in patients with occlusive carotid disease. A comparison with acetazolamide. Stroke 26, 1572-6.
157. Su C., Picard P., Rathbone M.P., and, Jiang S., (2010) Guanosine-induced decrease in side population of lung cancer cells: lack of correlation with ABCG2 expression. J. Biol. Regul. Homeost. Agents 24, 19-25.
158. Sweatt J.D., (2004) Mitogen-activated protein kinases in synaptic plasticity and memory. Curr. Opin. Neurobiol. 14, 311-7.
159. Sweeney M.I., (1997) Neuroprotective effects of adenosine in cerebral ischemia: window of opportunity. Neurosci. Biobehav. Rev. 21, 207-17.
160. Takahashi M., Mukai H., Toshimori M., Miyamoto M., and, Ono Y., (1998) Proteolytic activation of PKN by caspase-3 or related protease during apoptosis. Proc. Natl Acad. Sci. U S A 95, 11566-71.
161. Takahashi T., Otsuguro K., Ohta T., and, Ito S., (2010) Adenosine and inosine release during hypoxia in the isolated spinal cord of neonatal rats. Br. J. Pharmacol. 161, 1806-16.
162. Thauerer B., zur Nedden S., and, Baier-Bitterlich G., (2010) Vital role of protein kinase C-related kinase in the formation and stability of neurites during hypoxia. J. Neurochem. 113, 432-46.
163. Thomazi A.P., Boff B., Pires T.D., Godinho G., Battu C.E., Gottfried C., Souza D.O., Salbego C., and, Wofchuk S.T., (2008) Profile of glutamate uptake and cellular viability in hippocampal slices exposed to oxygen and glucose deprivation: developmental aspects and protection by guanosine. Brain Res. 1188, 233-40.
164. Tomaselli B., Podhraski V., Böck G., and, Baier-Bitterlich G., (2005a) Early cellular responses of purine nucleoside-mediated protection of hypoxia-induced injuries of neuronal PC12 cells. Am. J. Biochem. Biotechnol. 2, 161-167.
165. Tomaselli B., Podhraski V., Heftberger V., Bock G., and, Baier-Bitterlich G., (2005b) Purine nucleoside-mediated protection of chemical hypoxia-induced neuronal injuries involves p42/44 MAPK activation. Neurochem. Int. 46, 513-21.
166. Tomaselli B., Nedden S.Z., Podhraski V., and, Baier-Bitterlich G., (2008) p42/44 MAPK is an essential effector for purine nucleoside-mediated neuroprotection of hypoxic PC12 cells and primary cerebellar granule neurons. Mol. Cell. Neurosci. 38, 559-68.
167. Traversa U., Bombi G., Camaioni E., Macchiarulo A., Costantino G., Palmieri C., Caciagli F., and, Pellicciari R., (2003) Rat brain guanosine binding site Biological studies and pseudo-receptor construction. Bioorg. Med. Chem. 11, 5417-25.
168. Uemura Y., Miller J.M., Matson W.R., and, Beal M.F., (1991) Neurochemical analysis of focal ischemia in rats. Stroke 22, 1548-53.
169. Van Dycke A., Raedt R., Vonck K., and, Boon P., (2011) Local delivery strategies in epilepsy; a focus on adenosine. Seizure 20, 376-82.
170. Volpini R., Marucci G., Buccioni M., Dal Ben D., Lambertucci C., Lammi C., Mishra R.C., Thomas A., and, Cristalli G., (2011) Evidence for the existence of a specific g protein-coupled receptor activated by guanosine. ChemMedChem 6, 1074-80.
171. Wada T., and, Penninger J.M., (2004) Mitogen-activated protein kinases in apoptosis regulation. Oncogene 23, 2838-49.
172. Wang X., Zhu C., Qiu L., Hagberg H., Sandberg M., and, Blomgren K., (2003) Activation of ERK1/2 after neonatal rat cerebral hypoxia-ischaemia. J. Neurochem. 86, 351-62.
173. Wei C.J., Li W., and, Chen J.F., (2010) Normal and abnormal functions of adenosine receptors in the central nervous system revealed by genetic knockout studies. Biochim. Biophys. Acta 1808, 1358-79.
174. White B.C., Sullivan J.M., DeGracia D.J., O'Neil B.J., Neumar R.W., Grossman L.I., Rafols J.A., and, Krause G.S., (2000) Brain ischemia and reperfusion: molecular mechanisms of neuronal injury. J. Neurol. Sci. 179, 1-33.
175. Yawo H., and, Chuhma N., (1993) Preferential inhibition of omega-conotoxin-sensitive presynaptic Ca2+ channels by adenosine autoreceptors. Nature 365, 256-8.
176. Young A.R., Ali C., Duretete A., and, Vivien D., (2007) Neuroprotection and stroke: time for a compromise. J. Neurochem. 103, 1302-9.
177. Yuan J., and, Yankner B.A., (2000) Apoptosis in the nervous system. Nature 407, 802-9.
178. Yue X., Mehmet H., Penrice J., Cooper C., Cady E., Wyatt J.S., Reynolds E.O., Edwards A.D., and, Squier M.V., (1997) Apoptosis and necrosis in the newborn piglet brain following transient cerebral hypoxia-ischaemia. Neuropathol. Appl. Neurobiol. 23, 16-25.
179. Zai L., Ferrari C., Subbaiah S., Havton L.A., Coppola G., Strittmatter S., Irwin N., Geschwind D., and, Benowitz L.I., (2009) Inosine alters gene expression and axonal projections in neurons contralateral to a cortical infarct and improves skilled use of the impaired limb. J. Neurosci. 29, 8187-97.
180. Zhang D., Xiong W., Albensi B.C., and, Parkinson F.E., (2011) Expression of human equilibrative nucleoside transporter 1 in mouse neurons regulates adenosine levels in physiological and hypoxic-ischemic conditions. J. Neurochem. 118, 4-11.
181. Zhou Q.Y., Li C., Olah M.E., Johnson R.A., Stiles G.L., and, Civelli O., (1992) Molecular cloning and characterization of an adenosine receptor: the A3 adenosine receptor. Proc. Natl Acad. Sci. USA 89, 7432-6.
182. Zhu W.H., Conforti L., Czyzyk-Krzeska M.F., and, Millhorn D.E., (1996) Membrane depolarization in PC-12 cells during hypoxia is regulated by an O2-sensitive K+ current. Am. J. Physiol. 271, C658-65.
183. Zimmermann H., (2000) Extracellular metabolism of ATP and other nucleotides. Naunyn. Schmiedebergs. Arch. Pharmacol. 362, 299-309.
184. Zimmermann H., Braun N., Kegel B., and, Heine P., (1998) New insights into molecular structure and function of ectonucleotidases in the nervous system. Neurochem. Int. 32, 421-5.
185. Zurn A.D., and, Do K.Q., (1988) Purine metabolite inosine is an adrenergic neurotrophic substance for cultured chicken sympathetic neurons. Proc. Natl Acad. Sci. USA 85, 8301-5.